Literature DB >> 10780752

Development of severe hypoxaemia in chronic obstructive pulmonary disease patients at 2,438 m (8,000 ft) altitude.

C C Christensen1, M Ryg, O K Refvem, O H Skjønsberg.   

Abstract

The arterial oxygen tensions (Pa,02) in chronic obstructive pulmonary disease (COPD) patients travelling by air, should, according to two different guidelines, not be lower than 7.3 kPa (55 mmHg) and 6.7 kPa (50 mmHg), respectively, at a cabin pressure altitude of 2,438 m (8,000 ft). These minimum in-flight Pa,O2 values are claimed to correspond to a minimum Pa,O2 of 9.3 kPa (70 mmHg) at sea-level. The authors have tested whether this limit is a safe criterion for predicting severe in-flight hypoxaemia. The authors measured arterial blood gases at sea-level, at 2,438 m and at 3,048 m (10,000 ft) in an altitude chamber at rest and during light exercise in 15 COPD patients with forced expiratory volume in one second (FEV1) <50% of predicted, and with sea-level Pa,O2 >9.3 kPa. Resting Pa,O2 decreased below 7.3 kPa and 6.7 kPa in 53% and 33% of the patients, respectively, at 2,438 m, and in 86% and 66% of the patients at 3,048 m. During light exercise, Pa,O2 dropped below 6.7 kPa in 86% of the patients at 2,438 m, and in 100% of the patients at 3,048 m. There was no correlation between Pa,O2 at 2,438 m and pre-flight values of Pa,O2, FEV1 or transfer factor of the lung for carbon monoxide. In contrast to current medical guidelines, it has been found that resting arterial oxygen tension >9.3 kPa at sea-level does not exclude development of severe hypoxaemia in chronic obstructive pulmonary disease patients travelling by air. Light exercise, equivalent to slow walking along the aisle, may provoke a pronounced aggravation of the hypoxaemia.

Entities:  

Mesh:

Year:  2000        PMID: 10780752     DOI: 10.1183/09031936.00.15463500

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  15 in total

Review 1.  Emergency oxygen therapy for the COPD patient.

Authors:  R Murphy; P Driscoll; R O'Driscoll
Journal:  Emerg Med J       Date:  2001-09       Impact factor: 2.740

2.  Managing passengers with respiratory disease planning air travel: British Thoracic Society recommendations.

Authors: 
Journal:  Thorax       Date:  2002-04       Impact factor: 9.139

Review 3.  Oxygen: kill or cure? Prehospital hyperoxia in the COPD patient.

Authors:  A New
Journal:  Emerg Med J       Date:  2006-02       Impact factor: 2.740

4.  Lung disease at high altitude.

Authors:  Joshua O Stream; Andrew M Luks; Colin K Grissom
Journal:  Expert Rev Respir Med       Date:  2009-12       Impact factor: 3.772

5.  Air travel in women with lymphangioleiomyomatosis.

Authors:  Stacey Pollock-BarZiv; Marsha M Cohen; Gregory P Downey; Simon R Johnson; Eugene Sullivan; Francis X McCormack
Journal:  Thorax       Date:  2006-10-13       Impact factor: 9.139

6.  Effects of commercial air travel on patients with pulmonary hypertension air travel and pulmonary hypertension.

Authors:  Nareg Roubinian; C Gregory Elliott; Christopher F Barnett; Paul D Blanc; Joan Chen; Teresa De Marco; Hubert Chen
Journal:  Chest       Date:  2012-10       Impact factor: 9.410

7.  Effect of simulated commercial flight on oxygenation in patients with interstitial lung disease and chronic obstructive pulmonary disease.

Authors:  L M Seccombe; P T Kelly; C K Wong; P G Rogers; S Lim; M J Peters
Journal:  Thorax       Date:  2004-11       Impact factor: 9.139

Review 8.  [Air travel and respiratory diseases].

Authors:  Francisco García Río; Luis Borderías Clau; Ciro Casanova Macario; Bartolomé R Celli; Joan Escarrabill Sanglás; Nicolás González Mangado; Josep Roca Torrent; Fernando Uresandi Romero
Journal:  Arch Bronconeumol       Date:  2007-02       Impact factor: 4.872

9.  Predicting the need for supplemental oxygen during airline flight in patients with chronic pulmonary disease: a comparison of predictive equations and altitude simulation.

Authors:  Ana C Bradi; Marie E Faughnan; Matthew B Stanbrook; Eva Deschenes-Leek; Kenneth R Chapman
Journal:  Can Respir J       Date:  2009 Jul-Aug       Impact factor: 2.409

10.  Respiratory function and blood gas variables in cystic fibrosis patients during reduced environmental pressure.

Authors:  Oliver Thews; Birthe Fleck; Wolfgang E S Kamin; Dirk-Matthias Rose
Journal:  Eur J Appl Physiol       Date:  2004-08       Impact factor: 3.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.